LDX (ASX) LDX Discussion

LDX lumos diagnostics holdings limited

8.96%

7.3¢

First 966 Last

Share
Profile

Follow
Quest09

1,951 Posts.

181

05/12/24

14:00

Post #: 76932461
Share

Originally posted by Quest09: ↑

If an individual was to accept that LDX will likely achieve their short/medium term goals, then this analysis from an online article shows the upside potential available with the LDX share price.

According to the article:
- LDX has a price-to-sales (PS ratio) ratio of 1.3x
- half of all ASX med-tech companies have a PS ratio of 4.1x
- a PS ration of 15x are not unusual for med-tech stocks on the ASX

So, at a PS ratio of 1.3x, LDX can triple in share price and still be below the average PS ratio for med-tech stocks on the ASX, and can 12-times its current value and still be in-line with the PS ration of many med-tech stocks on the ASX.

Current LDX share price is 3 cents per share multiplied by the above stated PS ratios:
$0.03 cents*3 = $0.09 cents per share
$0.03 cents*12 = $0.36 cents per share

IMO, LDX is significantly undervalued and has a lot of upside potential.

Expand

Originally posted by Quest09: ↑

AMAZING.

This will make a significant difference to sales IMO.

=)

Expand

Originally posted by Quest09: ↑

I......TOLD.....YOU......SO....!

I was calling this out against a tide of negativity for ages....... still more to come with LDX.

Onwards and upwards.

=)

Expand

Looking at the LDX chart, today's breakout with a gap up looks strong.........and the breakout is holding onto gains quite well.

IMO, such a strong looking breakout is likely to continue into tomorrow's trading...and if we receive more news regarding the CLIA waiver clinical trial on Monday (or soon after), then we may still see another significant move in price action.

LDX looking strong IMO.

Onwards and upwards.

=)

Originally posted by Quest09: ↑

Current Total Available Market (TAM) is USD $118 million dollars per annum, meaning that LDX have a unique product which is of global importance and now have USA government support in terms of cost reimbursement for the use for their product.

IMO, and as the article posted below states, "if there is positive incentive for adoption such as the clinician or the facility getting paid then they will use the product".

Current TAM is USD $118 million dollars per annum which is massive and IMO will translate to an immediate and significant uptick in sales........but the crazy thing is that after the CLIA waiver the TAM will be USD $ 1.7 BILLION per annum.

IMO LDX is significantly undervalued.

=)

Expand

Originally posted by Quest09: ↑

LDX is holding onto today's gains quite well.

IMO, that is because the market is aware that today's announcement has significant long term positive outcomes for LDX and for LDX FebriDx sales.

IMO, this announcement could mean that LDX becomes cash flow positive in the very near future (as the above attached post indicates)......and of course a cash flow positive LDX would be significantly more valuable as a company than it is today.

So glad to be in a profitable position so early in this journey.

Onwards and upwards.

=)

Expand

LDX Price at posting: 3.9¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

NUZ

Neurizon inks $1.5M loan against R&D Tax Rebate

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

IXR

Ionic Rare Earths falls -7% as momentum slips on vague production update

HAR

Haranga jumps +7% on Lincoln acquisition

First 966 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 7.3¢		Change 0.006(8.96%)		Mkt cap ! $54.64M

Open	High	Low	Value	Volume
6.8¢	7.5¢	6.8¢	$874.7K	11.97M

Buyers (Bids)

No.	Vol.	Price($)
2	300000	7.2¢

Sellers (Offers)

Price($)	Vol.	No.
7.3¢	61016	1

View Market Depth

No.	Vol.	Price($)
2	300000	0.072
6	405951	0.071
4	880000	0.070
4	262000	0.069
6	1838000	0.068

Price($)	Vol.	No.
0.073	61016	1
0.074	178182	3
0.075	1357494	4
0.076	430228	7
0.077	641000	9

Last trade - 16.10pm 30/07/2025 (20 minute delay)

LDX (ASX) Chart

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

Neurizon inks $1.5M loan against R&D Tax Rebate

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

Ionic Rare Earths falls -7% as momentum slips on vague production update

Haranga jumps +7% on Lincoln acquisition

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Top Stories

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

Neurizon inks $1.5M loan against R&D Tax Rebate

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

Ionic Rare Earths falls -7% as momentum slips on vague production update

Haranga jumps +7% on Lincoln acquisition

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News